Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

All Articles

Nature Photography Is Healing My Spirit
After being diagnosed with a genetic mutation associated with immune disorders, including myelodysplastic syndromes and leukemia, Marit Chrislock had to give up her long-distance running in the Colorado mountains, using photography to express her love of nature. Read More ›

The Rite of Passage
Within the oncology world, there is a new controversy thick in the air—"Ringing of the bell." Read More ›

Healthy Food Habits for Colon Cancer Risk Reduction and Survivorship
Oncology dietitian Julie Lanford offers tips on how to reduce the risk of colon cancer, as well as strategies for survivors during and after cancer treatment. Read More ›

New All-Oral Combination Therapy for CLL Shows Impressive Results
A new study using a combination of the 2 oral drugs, Copiktra and Venclexta, showed promising results for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma. Read More ›

Brukinsa, a New BTK Inhibitor, Shows Impressive Results in Patients with CLL
Brukinsa, which was approved for use in patients with mantle-cell leukemia in late 2019, has also showed promising results in 2 recent clinical trials of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), including patients with high-risk genetic abnormalities. Read More ›

From Fly-Fishing to “Ringing the Bell”
Hello everyone and welcome to our February 2020 issue of CONQUER: the patient voice! Once again, we have packed many articles into this new issue to empower you with information, provide hope through inspirational stories from others, and perhaps help you look at the world with a different perspective. Read More ›

Permanent Hair Dyes and Chemical Hair Straighteners May Increase the Risk of Breast Cancer, Especially in Black Women

Defying the Odds: How I’ve Survived a Male-Dominated Terminal Cancer for 7 Years
Emily Ward was diagnosed with mesothelioma, a type of cancer usually associated with men who are exposed to asbestos. After working as a nurse for more than 40 years, her surprising diagnosis led to a search for the best care possible. Read More ›

What Your Doctor Should Know: Which Treatment Is Best for a Patient  with Relapsed or Refractory  Multiple Myeloma?
Many medications for multiple myeloma have been approved in recent years. That is great for patients, but it becomes even more important that doctors choose the best treatment for each patient. Read More ›

What Can You Expect with Cancer Immunotherapy?
Immunotherapy is offering exciting new treatments for many types of cancer. It works by revving up the immune system and can have various side effects in different patients. Read More ›

Page 83 of 164